Literature DB >> 16545695

H2O2 injury in beta thalassemic erythrocytes: protective role of catalase and the prooxidant effects of GSH.

Mark D Scott1.   

Abstract

Redox-mediated injury is an important pathway in the destruction of beta thalassemic red blood cells (RBC). Because of the autoxidation of the unstable hemoglobin chains and subsequent release of globin free heme and iron, significant amounts of superoxide (O2-) and, more importantly, hydrogen peroxide (H2O2) are generated intracellularly. Hence, catabolism of H2O2 is crucial in preventing cellular injury. Removal of H2O2 is mediated via two primary pathways: GSH-dependent glutathione peroxidase or catalase. Importantly, both pathways are ultimately dependent on NADPH. In the absence of any exogenous oxidants, model thalassemic RBC demonstrated significantly decreased GSH levels (P < 0.001 at 20 h). Perhaps of greater pathophysiologic importance, however, was the finding that the model thalassemic RBC exhibited significantly (P < 0.001) decreased catalase activity. Following 20 h incubation at 37 degrees C only 61.5 +/- 2.9% of the initial catalase activity remained in the alpha-hemoglobin chain-loaded cells versus 104.6 +/- 4.5 and 108.2 +/- 3.2% in the control and control-resealed cells, respectively. The mechanism underlying the loss of both catalase activity and GSH appears to be the same in that both catabolic pathways require adequate NADPH levels. As shown in this study, model beta thalassemic cells are unable to maintain a normal ( approximately 1.0) NADPH/NADP(total) ratio and, after 20 h, the model beta thalassemic cells have a significantly (P < 0.001) lower ratio ( approximately 0.5) which is quite similar to a G6PD-deficient RBC. In support of these findings, direct inactivation of catalase gives rise to significantly increased oxidant damage. In contrast, GSH depletion is not closely associated with oxidant sensitivity. Indeed, the consumption of GSH noted in the thalassemic RBC may be via a prooxidant pathway as augmentation of cellular GSH levels actually enhances alpha-hemoglobin chain-mediated injury.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16545695     DOI: 10.1016/j.freeradbiomed.2005.11.017

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  11 in total

1.  Oxidative stress and labile plasmatic iron in anemic patients following blood therapy.

Authors:  Marília Sabo Fernandes; Tatiana Tamborena Rissi; Luisa Zuravski; Juliana Mezzomo; Carmen Regla Vargas; Vanderlei Folmer; Félix Alexandre Antunes Soares; Vanusa Manfredini; Mushtaq Ahmed; Robson Luiz Puntel
Journal:  World J Exp Med       Date:  2014-08-20

2.  A transgenic mouse model expressing exclusively human hemoglobin E: indications of a mild oxidative stress.

Authors:  Qiuying Chen; Mary E Fabry; Anne C Rybicki; Sandra M Suzuka; Tatiana C Balazs; Zipora Etzion; Kitty de Jong; Edna K Akoto; Joseph E Canterino; Dhananjay K Kaul; Frans A Kuypers; David Lefer; Eric E Bouhassira; Rhoda Elison Hirsch
Journal:  Blood Cells Mol Dis       Date:  2012-01-18       Impact factor: 3.039

3.  Peroxiredoxin-2 expression is increased in beta-thalassemic mouse red cells but is displaced from the membrane as a marker of oxidative stress.

Authors:  Alessandro Matte; Philip S Low; Franco Turrini; Mariarita Bertoldi; Maria Estela Campanella; Daniela Spano; Antonella Pantaleo; Angela Siciliano; Lucia De Franceschi
Journal:  Free Radic Biol Med       Date:  2010-05-19       Impact factor: 7.376

4.  Effects of Vitamin E and Zinc Supplementation on Antioxidants in Beta thalassemia major Patients.

Authors:  Mohammadreza Rashidi; Maryam Aboomardani; Maryam Rafraf; Seyed-Rafie Arefhosseini; Abbasali Keshtkar; Hamidreza Joshaghani
Journal:  Iran J Pediatr       Date:  2011-03       Impact factor: 0.364

5.  Allicin modulates the antioxidation and detoxification capabilities of primary rat hepatocytes.

Authors:  Chih-Chung Wu; Yung-Lin Chu; Lee-Yan Sheen
Journal:  J Tradit Complement Med       Date:  2012-10

6.  Detection of glycemic abnormalities in adolescents with beta thalassemia using continuous glucose monitoring and oral glucose tolerance in adolescents and young adults with β-thalassemia major: Pilot study.

Authors:  Ashraf T Soliman; Mohamed Yasin; Ahmed El-Awwa; Vincenzo De Sanctis
Journal:  Indian J Endocrinol Metab       Date:  2013-05

7.  Oxidative stress and antioxidant status in beta-thalassemia heterozygotes.

Authors:  Luciana de Souza Ondei; Isabeth da Fonseca Estevão; Marina Ibelli Pereira Rocha; Sandro Percário; Dorotéia Rossi Silva Souza; Marcela Augusta de Souza Pinhel; Claudia Regina Bonini-Domingos
Journal:  Rev Bras Hematol Hemoter       Date:  2013

8.  The Benefits of vitamin E on liver function and the hemopoietic System in thalassemia Patients.

Authors:  Z Hashemian; A Hashemi; M Fateminasab
Journal:  Iran J Ped Hematol Oncol       Date:  2012-09-22

Review 9.  Desferrithiocin: a search for clinically effective iron chelators.

Authors:  Raymond J Bergeron; Jan Wiegand; James S McManis; Neelam Bharti
Journal:  J Med Chem       Date:  2014-09-10       Impact factor: 7.446

Review 10.  Oxidative stress and age-related changes in T cells: is thalassemia a model of accelerated immune system aging?

Authors:  Mahdi Ghatreh-Samani; Nafiseh Esmaeili; Masoud Soleimani; Majid Asadi-Samani; Keihan Ghatreh-Samani; Hedayatolah Shirzad
Journal:  Cent Eur J Immunol       Date:  2016-01-20       Impact factor: 2.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.